Vince McMahon open to leaving WWE for good if he sells the company, CEO Nick Khan says

Vince McMahon open to leaving WWE for good if he sells the company, CEO Nick Khan says


Vince McMahon attends a press conference at MetLife Stadium on February 16, 2012 in East Rutherford, New Jersey.

Michael N. Todaro | Getty Images

World Wrestling Entertainment Executive Chairman Vince McMahon is open to stepping away from the company “if it’s the right deal,” according to WWE CEO Nick Khan.

Shares of the company closed more than 5% higher Friday.

related investing news

Nordstrom could use an activist, but Ryan Cohen might not be the right one

CNBC Pro

McMahon’s potential future involvement in WWE has become an early sticking point in preliminary talks with various buyers, according to people familiar with the matter, who asked not to be named because the discussions are private.

McMahon is WWE’s controlling shareholder. He developed the creative storylines for the professional wrestling league for decades, often taking part in narratives himself. Earlier this year, he stepped down as head of creative, handing the reigns to his son-in-law, former WWE superstar Paul “Triple H” Levesque. Khan took over as sole CEO in January when Levesque’s wife and McMahon’s daughter, Stephanie, stepped down as co-CEO.

“Vince has declared to the board he’s 100% open to transactions where he’s not included in the company moving forward,” Khan said in a CNBC interview Friday.

McMahon stepped away from his CEO role in June amid accusations of sexual misconduct from former female WWE employees. A month later, he announced he announced he would retire from the wrestling company he bought from his father over four decades ago. Last month, however, McMahon returned to the board to be directly involved in sale negotiations with potential buyers.

WWE has hired financial advisors to proceed with a sale process, which Khan predicted would last about three months. Khan emphasized WWE could be appealing to a large media company with a streaming platform that could increase subscribers by exclusively owning WWE’s monthly live events, along with its historical library of past matches.

“We feel the marketplace is robust for our product,” Khan said. “It’s in essence it’s own sports league. Someone can buy it and put it on their platform.”

Potential buyers for WWE include Comcast, Netflix, Liberty Media and Endeavor, which already owns UFC.

Khan acknowledged “it’s tough to take control” from McMahon, who has owned and run WWE (previously WWF) for more than 40 years. Still, he reiterated that McMahon would prioritize shareholder value and step away “if it’s the right deal — and we will take a look at all of the factors that make it the right deal.”

Disclosure: Comcast is the parent company of NBCUniversal, which owns CNBC.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More